Glaucoma Biomarkers

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 30, 2016

Study Completion Date

August 30, 2016

Conditions
GlaucomaHealthy
Interventions
DRUG

Variation in eye pressure response to timolol and latanoprost treatment

Arm 1 is to test for variation in eye pressure response to timolol. Arm 2 is to test for variation in eye pressure response to latanoprost.

Trial Locations (3)

48105

University of Michigan, Ann Arbor

Unknown

Mayo Clinic, Rochester

University of Nebraska Medical Center, Omaha

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Nebraska

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

National Eye Institute (NEI)

NIH

lead

University of Michigan

OTHER

NCT01677507 - Glaucoma Biomarkers | Biotech Hunter | Biotech Hunter